Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $78.33, with a high estimate of $82.00 and a low estimate of $67.00. Marking an increase of 2 ...

Q2 2025 Earnings Call Transcript August 13, 2025 ARS Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $ ...

Diversified healthcare company CVS Health (NYSE:CVS) in Q2 CY2025, with sales up 8.4% year on year to $98.92 billion. Its non ...

Through the power of strategic, well-built partnerships, CVS Health helps employees earn degrees — and at no cost to them.

CVS Health reported an impressive adjusted operating income of $3.8 billion and an adjusted EPS of $1.81. The company has also increased its full-year 2025 adjusted EPS guidance to a range of $6.30 to ...

Joshua Fredell, Pharm.D., senior vice president at CVS Caremark and PBMI Innovator Award winner, is calling for a PBM industry focus on making pharmacy experiences more seamless while continuing to ...

As drug companies increasingly adopt the DTC sales model, patients will gain the ability to buy the medicines they need at ...

CVS Caremark owes the State of West Virginia $1.4 million in civil penalties after the state’s insurance commissioner found ...